News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Features Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019 Caitlin E. Cox December 17, 2019
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Features To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death Caitlin E. Cox May 02, 2018
News Features Despite New Findings, Optimal DAPT Duration Still Up in the Air Todd Neale December 10, 2014
News Features Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3 June 24, 2014
News Features FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel Caitlin E. Cox May 07, 2012